English

SPECTRUM PHARMACEUTICALS INC

EDGAR

SPPI Quarterly report (10-Q) · filed 2023-05-11

161 filing records in this dataset, filed from 1996-11-12 to 2023-05-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

15.6 million USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 15615000 USD Source

Operating margin

-31.19%

2023 Q1 · %

Exact inputs and evidence

Operating Income: -4870000 USD Source
Revenue: 15615000 USD Source

Operating cash flow

-21.4 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -21440000 USD Source

Free cash flow

-21.5 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -21440000 USD Source
Capital Expenditure: 108000 USD Source

Cash and cash equivalents: 52.4 million USD 2023-03-31 Source
Exact value

52373000 USD
Long-term debt including current maturities: 28.8 million USD 2023-03-31 Source
Exact value

28840000 USD
Shares outstanding: 205 million shares 2023-03-31 Source
Exact value

205284506 shares

Reported share-count change

14.79% · 26.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

178827485 shares · 2022-03-31· Source
205284506 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-65 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: -29048000 USD · 2022-04-01 – 2022-06-30 Source
Net income: -21925000 USD · 2022-07-01 – 2022-09-30 Source
Net income: -75401000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -66415000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -5007000 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

-88.1 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -53742000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -30296000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -71651000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -53742000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -96989000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -71651000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -21440000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

342 thousand USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Capital expenditure: 45000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 39000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 273000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 108000 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-88.5 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: -53742000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -30296000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: -71651000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -53742000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: -96989000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -71651000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -21440000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 39000 USD · 2022-01-01 – 2022-03-31 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 273000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 45000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 108000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-05-11.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 11 of 11 periods available· newest 2022-12-31
Total assets: 11 of 11 periods available· newest 2022-12-31
Total liabilities: 11 of 11 periods available· newest 2022-12-31
Current assets: 11 of 11 periods available· newest 2022-12-31
Current liabilities: 11 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
Shares outstanding: 11 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+USD 10.11 million

Prior period

USD 0

2021-01-01 – 2021-12-31
Current period

USD 10.11 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

10114000 − 0 = 10114000 USD

0 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
10114000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Year-over-year change in Revenue: 10114000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 10114000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#935985 Filing: 000083154723000007 Input fundies:Revenue: 0 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#936943 Filing: 000083154723000007
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 83.23 million

Prior period

−USD 158.63 million

2021-01-01 – 2021-12-31
Current period

−USD 75.4 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-75401000 − -158628000 = 83227000 USD

-158628000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-75401000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Year-over-year change in Net income: 83227000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -75401000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1098078 Filing: 000083154723000007 Input fundies:NetIncome: -158628000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1098762 Filing: 000083154723000007
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 22.5 million

Prior period

−USD 119.49 million

2021-01-01 – 2021-12-31
Current period

−USD 96.99 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-96989000 − -119486000 = 22497000 USD

-119486000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-96989000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Year-over-year change in Operating cash flow: 22497000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -96989000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1134497 Filing: 000083154723000007 Input fundies:OperatingCashFlow: -119486000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1135210 Filing: 000083154723000007
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+23.5%

Prior period

USD 221,000

2021-01-01 – 2021-12-31
Current period

USD 273,000

2022-01-01 – 2022-12-31

Exact inputs and evidence

273000 − 221000 = 52000 USD

221000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
273000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Year-over-year change in Capital expenditure: 52000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 273000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1142516 Filing: 000083154723000007 Input fundies:CapitalExpenditure: 221000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1143136 Filing: 000083154723000007
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 10.11 million 100% of revenue
Operating costs Derived USD 82.81 million 819% of revenue
Operating income −USD 72.7 million −719% of revenue
Tax, interest and other Derived USD 2.7 million 27% of revenue
Net income −USD 75.4 million −746% of revenue

Cash

Operating cash flow −USD 96.99 million −959% of revenue
Capital expenditure USD 273,000 2.7% of revenue
Free cash flow Derived −USD 97.26 million −962% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 125% of revenue.
2014 Operating loss: operating costs were 117% of revenue.
2015 Operating loss: operating costs were 126% of revenue.
2016 Operating loss: operating costs were 143% of revenue.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Operating loss: operating costs were 819% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	155854000	194639000 Derived	-38785000	23349000 Derived	-62134000	-2247000 Derived	Source 2013-01-01 – 2013-12-31: 155854000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -38785000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -62134000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -2086000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 161000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	186830000	218399000 Derived	-31569000	14150000 Derived	-45719000	-4561000 Derived	Source 2014-01-01 – 2014-12-31: 186830000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -31569000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -45719000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -3627000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 934000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	162556000	205145000 Derived	-42589000	10053000 Derived	-52642000	6521000 Derived	Source 2015-01-01 – 2015-12-31: 162556000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -42589000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -52642000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 6744000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 223000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	146444000	209330000 Derived	-62886000	6884000 Derived	-69770000	-40537000 Derived	Source 2016-01-01 – 2016-12-31: 146444000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -62886000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -69770000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -40459000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 78000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	116284000 Derived	-116284000	-24095000 Derived	-92189000	-39320000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -116284000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -92189000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -38855000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 465000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	137847000 Derived	-137847000	-17106000 Derived	-120741000	-62510000 Derived	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -137847000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -120741000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -62403000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 107000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	0	140698000 Derived	-140698000	-28009000 Derived	-112689000	-143649000 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -140698000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -112689000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -134631000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 9018000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	0	169734000 Derived	-169734000	-8866000 Derived	-160868000	-127164000 Derived	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -169734000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -160868000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -121629000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5535000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	0	147703000 Derived	-147703000	10925000 Derived	-158628000	-119707000 Derived	Source 2021-01-01 – 2021-12-31: 0 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -147703000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -158628000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -119486000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 221000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	10114000	82811000 Derived	-72697000	2704000 Derived	-75401000	-97262000 Derived	Source 2022-01-01 – 2022-12-31: 10114000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -72697000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -75401000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -96989000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 273000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 10.1M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	155854000	Revenue: 155854000 Open source
20142014-12-31	Revenue	186830000	Revenue: 186830000 Open source
20152015-12-31	Revenue	162556000	Revenue: 162556000 Open source
20162016-12-31	Revenue	146444000	Revenue: 146444000 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	0	Revenue: 0 Open source
20212021-12-31	Revenue	0	Revenue: 0 Open source
20222022-12-31	Revenue	10114000	Revenue: 10114000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	-38.9%	Revenue: 155854000 Open source Revenue: 254992000 Open source
20142014-12-31	Year over year	19.9%	Revenue: 186830000 Open source Revenue: 155854000 Open source
20152015-12-31	Year over year	-13%	Revenue: 162556000 Open source Revenue: 186830000 Open source
20162016-12-31	Year over year	-9.9%	Revenue: 146444000 Open source Revenue: 162556000 Open source
20172017-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 146444000 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20222022-12-31	Year over year	No prior comparable period	Revenue: 10114000 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -718.8% 2022

Net margin -745.5% 2022

Free cash flow margin -961.7% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	-24.9%	Operating Income: -38785000 Open source Revenue: 155854000 Open source
20142014-12-31	Operating margin	-16.9%	Operating Income: -31569000 Open source Revenue: 186830000 Open source
20152015-12-31	Operating margin	-26.2%	Operating Income: -42589000 Open source Revenue: 162556000 Open source
20162016-12-31	Operating margin	-42.9%	Operating Income: -62886000 Open source Revenue: 146444000 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -116284000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -137847000 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -140698000 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	Not reported	Operating Income: -169734000 Open source Revenue: 0 Open source
20212021-12-31	Operating margin	Not reported	Operating Income: -147703000 Open source Revenue: 0 Open source
20222022-12-31	Operating margin	-718.8%	Operating Income: -72697000 Open source Revenue: 10114000 Open source
20132013-12-31	Net margin	-39.9%	Net Income: -62134000 Open source Revenue: 155854000 Open source
20142014-12-31	Net margin	-24.5%	Net Income: -45719000 Open source Revenue: 186830000 Open source
20152015-12-31	Net margin	-32.4%	Net Income: -52642000 Open source Revenue: 162556000 Open source
20162016-12-31	Net margin	-47.6%	Net Income: -69770000 Open source Revenue: 146444000 Open source
20172017-12-31	Net margin	Not reported	Net Income: -92189000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -120741000 Open source Revenue: 0 Open source
20192019-12-31	Net margin	Not reported	Net Income: -112689000 Open source Revenue: 0 Open source
20202020-12-31	Net margin	Not reported	Net Income: -160868000 Open source Revenue: 0 Open source
20212021-12-31	Net margin	Not reported	Net Income: -158628000 Open source Revenue: 0 Open source
20222022-12-31	Net margin	-745.5%	Net Income: -75401000 Open source Revenue: 10114000 Open source
20132013-12-31	Free cash flow margin	-1.4%	Revenue: 155854000 Open source Operating Cash Flow: -2086000 Open source Capital Expenditure: 161000 Open source
20142014-12-31	Free cash flow margin	-2.4%	Revenue: 186830000 Open source Operating Cash Flow: -3627000 Open source Capital Expenditure: 934000 Open source
20152015-12-31	Free cash flow margin	4%	Revenue: 162556000 Open source Operating Cash Flow: 6744000 Open source Capital Expenditure: 223000 Open source
20162016-12-31	Free cash flow margin	-27.7%	Revenue: 146444000 Open source Operating Cash Flow: -40459000 Open source Capital Expenditure: 78000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -38855000 Open source Capital Expenditure: 465000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -62403000 Open source Capital Expenditure: 107000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -134631000 Open source Capital Expenditure: 9018000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -121629000 Open source Capital Expenditure: 5535000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -119486000 Open source Capital Expenditure: 221000 Open source
20222022-12-31	Free cash flow margin	-961.7%	Revenue: 10114000 Open source Operating Cash Flow: -96989000 Open source Capital Expenditure: 273000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -97M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	-2086000	Operating Cash Flow: -2086000 Open source
20142014-12-31	Operating cash flow	-3627000	Operating Cash Flow: -3627000 Open source
20152015-12-31	Operating cash flow	6744000	Operating Cash Flow: 6744000 Open source
20162016-12-31	Operating cash flow	-40459000	Operating Cash Flow: -40459000 Open source
20172017-12-31	Operating cash flow	-38855000	Operating Cash Flow: -38855000 Open source
20182018-12-31	Operating cash flow	-62403000	Operating Cash Flow: -62403000 Open source
20192019-12-31	Operating cash flow	-134631000	Operating Cash Flow: -134631000 Open source
20202020-12-31	Operating cash flow	-121629000	Operating Cash Flow: -121629000 Open source
20212021-12-31	Operating cash flow	-119486000	Operating Cash Flow: -119486000 Open source
20222022-12-31	Operating cash flow	-96989000	Operating Cash Flow: -96989000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -97.3M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	-2247000	Operating Cash Flow: -2086000 Open source Capital Expenditure: 161000 Open source
20142014-12-31	Free cash flow	-4561000	Operating Cash Flow: -3627000 Open source Capital Expenditure: 934000 Open source
20152015-12-31	Free cash flow	6521000	Operating Cash Flow: 6744000 Open source Capital Expenditure: 223000 Open source
20162016-12-31	Free cash flow	-40537000	Operating Cash Flow: -40459000 Open source Capital Expenditure: 78000 Open source
20172017-12-31	Free cash flow	-39320000	Operating Cash Flow: -38855000 Open source Capital Expenditure: 465000 Open source
20182018-12-31	Free cash flow	-62510000	Operating Cash Flow: -62403000 Open source Capital Expenditure: 107000 Open source
20192019-12-31	Free cash flow	-143649000	Operating Cash Flow: -134631000 Open source Capital Expenditure: 9018000 Open source
20202020-12-31	Free cash flow	-127164000	Operating Cash Flow: -121629000 Open source Capital Expenditure: 5535000 Open source
20212021-12-31	Free cash flow	-119707000	Operating Cash Flow: -119486000 Open source Capital Expenditure: 221000 Open source
20222022-12-31	Free cash flow	-97262000	Operating Cash Flow: -96989000 Open source Capital Expenditure: 273000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

73% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Liabilities / assets	43.6%	Total Liabilities: 217549000 Open source Total Assets: 499155000 Open source
20142014-12-31	Liabilities / assets	48.1%	Total Liabilities: 235479000 Open source Total Assets: 490033000 Open source
20152015-12-31	Liabilities / assets	49.2%	Total Liabilities: 206192000 Open source Total Assets: 419049000 Open source
20162016-12-31	Liabilities / assets	45%	Total Liabilities: 192742000 Open source Total Assets: 428768000 Open source
20172017-12-31	Liabilities / assets	27.9%	Total Liabilities: 136100000 Open source Total Assets: 487439000 Open source
20182018-12-31	Liabilities / assets	30.6%	Total Liabilities: 119476000 Open source Total Assets: 390886000 Open source
20192019-12-31	Liabilities / assets	27.7%	Total Liabilities: 73040000 Open source Total Assets: 263433000 Open source
20202020-12-31	Liabilities / assets	31.8%	Total Liabilities: 62555000 Open source Total Assets: 196798000 Open source
20212021-12-31	Liabilities / assets	57.4%	Total Liabilities: 63995000 Open source Total Assets: 111548000 Open source
20222022-12-31	Liabilities / assets	73%	Total Liabilities: 75450000 Open source Total Assets: 103338000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.37× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	2.61×	Current Assets: 235190000 Open source Current Liabilities: 89984000 Open source
20142014-12-31	Current assets / current liabilities	2.03×	Current Assets: 222469000 Open source Current Liabilities: 109439000 Open source
20152015-12-31	Current assets / current liabilities	2.5×	Current Assets: 190625000 Open source Current Liabilities: 76343000 Open source
20162016-12-31	Current assets / current liabilities	3.31×	Current Assets: 216650000 Open source Current Liabilities: 65513000 Open source
20172017-12-31	Current assets / current liabilities	2.53×	Current Assets: 277746000 Open source Current Liabilities: 109749000 Open source
20182018-12-31	Current assets / current liabilities	2.55×	Current Assets: 250688000 Open source Current Liabilities: 98326000 Open source
20192019-12-31	Current assets / current liabilities	3.94×	Current Assets: 244020000 Open source Current Liabilities: 61970000 Open source
20202020-12-31	Current assets / current liabilities	3.51×	Current Assets: 186647000 Open source Current Liabilities: 53146000 Open source
20212021-12-31	Current assets / current liabilities	1.95×	Current Assets: 103952000 Open source Current Liabilities: 53229000 Open source
20222022-12-31	Current assets / current liabilities	2.37×	Current Assets: 101011000 Open source Current Liabilities: 42685000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 62.13 million Exact value Exact value: -62134000 USD 2013-01-01 – 2013-12-31: -62134000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2013-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -62134000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62134000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154716000059/sppi-20151231.xml#525690 Filing: 000083154716000059 The citation records this snapshot. The page link may show a newer release later.	−USD 2.09 million Exact value Exact value: -2086000 USD 2013-01-01 – 2013-12-31: -2086000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2013-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -2086000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2086000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154716000059/sppi-20151231.xml#525058 Filing: 000083154716000059 The citation records this snapshot. The page link may show a newer release later.	USD 161,000 Exact value Exact value: 161000 USD 2013-01-01 – 2013-12-31: 161000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2013-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 161000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 161000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154716000059/sppi-20151231.xml#547735 Filing: 000083154716000059 The citation records this snapshot. The page link may show a newer release later.	−USD 2.25 million Calculation and evidence -2086000 − 161000 USD Exact free cash flow: -2247000 USD 2013-01-01 – 2013-12-31: -2086000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 161000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2013-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -2247000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2086000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154716000059/sppi-20151231.xml#525058 Filing: 000083154716000059 Input fundies:CapitalExpenditure: 161000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154716000059/sppi-20151231.xml#547735 Filing: 000083154716000059 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 45.72 million Exact value Exact value: -45719000 USD 2014-01-01 – 2014-12-31: -45719000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2014-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -45719000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45719000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154717000020/sppi-20161231.xml#579600 Filing: 000083154717000020 The citation records this snapshot. The page link may show a newer release later.	−USD 3.63 million Exact value Exact value: -3627000 USD 2014-01-01 – 2014-12-31: -3627000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2014-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -3627000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3627000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154717000020/sppi-20161231.xml#578967 Filing: 000083154717000020 The citation records this snapshot. The page link may show a newer release later.	USD 934,000 Exact value Exact value: 934000 USD 2014-01-01 – 2014-12-31: 934000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2014-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 934000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 934000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154717000020/sppi-20161231.xml#603124 Filing: 000083154717000020 The citation records this snapshot. The page link may show a newer release later.	−USD 4.56 million Calculation and evidence -3627000 − 934000 USD Exact free cash flow: -4561000 USD 2014-01-01 – 2014-12-31: -3627000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 934000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2014-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -4561000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3627000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154717000020/sppi-20161231.xml#578967 Filing: 000083154717000020 Input fundies:CapitalExpenditure: 934000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154717000020/sppi-20161231.xml#603124 Filing: 000083154717000020 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 52.64 million Exact value Exact value: -52642000 USD 2015-01-01 – 2015-12-31: -52642000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2015-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -52642000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52642000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154718000015/sppi-20171231.xml#639456 Filing: 000083154718000015 The citation records this snapshot. The page link may show a newer release later.	USD 6.74 million Exact value Exact value: 6744000 USD 2015-01-01 – 2015-12-31: 6744000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2015-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: 6744000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6744000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154718000015/sppi-20171231.xml#638822 Filing: 000083154718000015 The citation records this snapshot. The page link may show a newer release later.	USD 223,000 Exact value Exact value: 223000 USD 2015-01-01 – 2015-12-31: 223000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2015-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 223000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 223000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154718000015/sppi-20171231.xml#665974 Filing: 000083154718000015 The citation records this snapshot. The page link may show a newer release later.	USD 6.52 million Calculation and evidence 6744000 − 223000 USD Exact free cash flow: 6521000 USD 2015-01-01 – 2015-12-31: 6744000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 223000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2015-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: 6521000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6744000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154718000015/sppi-20171231.xml#638822 Filing: 000083154718000015 Input fundies:CapitalExpenditure: 223000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154718000015/sppi-20171231.xml#665974 Filing: 000083154718000015 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 69.77 million Exact value Exact value: -69770000 USD 2016-01-01 – 2016-12-31: -69770000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2016-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -69770000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -69770000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154719000006/sppi-20181231.xml#683367 Filing: 000083154719000006 The citation records this snapshot. The page link may show a newer release later.	−USD 40.46 million Exact value Exact value: -40459000 USD 2016-01-01 – 2016-12-31: -40459000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2016-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -40459000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40459000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154719000006/sppi-20181231.xml#682731 Filing: 000083154719000006 The citation records this snapshot. The page link may show a newer release later.	USD 78,000 Exact value Exact value: 78000 USD 2016-01-01 – 2016-12-31: 78000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2016-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 78000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 78000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154719000006/sppi-20181231.xml#710005 Filing: 000083154719000006 The citation records this snapshot. The page link may show a newer release later.	−USD 40.54 million Calculation and evidence -40459000 − 78000 USD Exact free cash flow: -40537000 USD 2016-01-01 – 2016-12-31: -40459000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 78000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2016-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -40537000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40459000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154719000006/sppi-20181231.xml#682731 Filing: 000083154719000006 Input fundies:CapitalExpenditure: 78000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154719000006/sppi-20181231.xml#710005 Filing: 000083154719000006 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 92.19 million Exact value Exact value: -92189000 USD 2017-01-01 – 2017-12-31: -92189000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2017-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -92189000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -92189000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#2910636 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	−USD 38.86 million Exact value Exact value: -38855000 USD 2017-01-01 – 2017-12-31: -38855000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2017-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -38855000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38855000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1465708 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	USD 465,000 Exact value Exact value: 465000 USD 2017-01-01 – 2017-12-31: 465000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2017-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 465000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 465000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1481537 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	−USD 39.32 million Calculation and evidence -38855000 − 465000 USD Exact free cash flow: -39320000 USD 2017-01-01 – 2017-12-31: -38855000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 465000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2017-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -39320000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38855000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1465708 Filing: 000083154720000009 Input fundies:CapitalExpenditure: 465000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1481537 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 120.74 million Exact value Exact value: -120741000 USD 2018-01-01 – 2018-12-31: -120741000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2018-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -120741000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -120741000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#2898947 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	−USD 62.4 million Exact value Exact value: -62403000 USD 2018-01-01 – 2018-12-31: -62403000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2018-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -62403000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62403000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1464738 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	USD 107,000 Exact value Exact value: 107000 USD 2018-01-01 – 2018-12-31: 107000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2018-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 107000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 107000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1480645 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.	−USD 62.51 million Calculation and evidence -62403000 − 107000 USD Exact free cash flow: -62510000 USD 2018-01-01 – 2018-12-31: -62403000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 107000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2018-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -62510000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62403000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1464738 Filing: 000083154720000009 Input fundies:CapitalExpenditure: 107000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154720000009/sppi-201910xk.htm#1480645 Filing: 000083154720000009 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 112.69 million Exact value Exact value: -112689000 USD 2019-01-01 – 2019-12-31: -112689000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2019-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -112689000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -112689000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154721000009/sppi-20201231.htm#1068865 Filing: 000083154721000009 The citation records this snapshot. The page link may show a newer release later.	−USD 134.63 million Exact value Exact value: -134631000 USD 2019-01-01 – 2019-12-31: -134631000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2019-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -134631000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -134631000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154721000009/sppi-20201231.htm#1127160 Filing: 000083154721000009 The citation records this snapshot. The page link may show a newer release later.	USD 9.02 million Exact value Exact value: 9018000 USD 2019-01-01 – 2019-12-31: 9018000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2019-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 9018000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9018000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154721000009/sppi-20201231.htm#1139759 Filing: 000083154721000009 The citation records this snapshot. The page link may show a newer release later.	−USD 143.65 million Calculation and evidence -134631000 − 9018000 USD Exact free cash flow: -143649000 USD 2019-01-01 – 2019-12-31: -134631000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 9018000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2019-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -143649000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -134631000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154721000009/sppi-20201231.htm#1127160 Filing: 000083154721000009 Input fundies:CapitalExpenditure: 9018000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154721000009/sppi-20201231.htm#1139759 Filing: 000083154721000009 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 160.87 million Exact value Exact value: -160868000 USD 2020-01-01 – 2020-12-31: -160868000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2020-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -160868000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -160868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154722000014/sppi-20211231.htm#1041130 Filing: 000083154722000014 The citation records this snapshot. The page link may show a newer release later.	−USD 121.63 million Exact value Exact value: -121629000 USD 2020-01-01 – 2020-12-31: -121629000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2020-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -121629000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -121629000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154722000014/sppi-20211231.htm#1087543 Filing: 000083154722000014 The citation records this snapshot. The page link may show a newer release later.	USD 5.54 million Exact value Exact value: 5535000 USD 2020-01-01 – 2020-12-31: 5535000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2020-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 5535000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5535000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154722000014/sppi-20211231.htm#1098159 Filing: 000083154722000014 The citation records this snapshot. The page link may show a newer release later.	−USD 127.16 million Calculation and evidence -121629000 − 5535000 USD Exact free cash flow: -127164000 USD 2020-01-01 – 2020-12-31: -121629000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5535000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2020-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -127164000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -121629000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154722000014/sppi-20211231.htm#1087543 Filing: 000083154722000014 Input fundies:CapitalExpenditure: 5535000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154722000014/sppi-20211231.htm#1098159 Filing: 000083154722000014 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 158.63 million Exact value Exact value: -158628000 USD 2021-01-01 – 2021-12-31: -158628000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2021-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -158628000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -158628000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1098762 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 119.49 million Exact value Exact value: -119486000 USD 2021-01-01 – 2021-12-31: -119486000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2021-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -119486000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -119486000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1135210 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	USD 221,000 Exact value Exact value: 221000 USD 2021-01-01 – 2021-12-31: 221000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2021-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 221000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 221000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1143136 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 119.71 million Calculation and evidence -119486000 − 221000 USD Exact free cash flow: -119707000 USD 2021-01-01 – 2021-12-31: -119486000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 221000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2021-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -119707000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -119486000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1135210 Filing: 000083154723000007 Input fundies:CapitalExpenditure: 221000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1143136 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 75.4 million Exact value Exact value: -75401000 USD 2022-01-01 – 2022-12-31: -75401000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Net Income: -75401000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75401000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1098078 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 96.99 million Exact value Exact value: -96989000 USD 2022-01-01 – 2022-12-31: -96989000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Operating Cash Flow: -96989000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -96989000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1134497 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	USD 273,000 Exact value Exact value: 273000 USD 2022-01-01 – 2022-12-31: 273000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Capital Expenditure: 273000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 273000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1142516 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.	−USD 97.26 million Calculation and evidence -96989000 − 273000 USD Exact free cash flow: -97262000 USD 2022-01-01 – 2022-12-31: -96989000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 273000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SPECTRUM PHARMACEUTICALS INC · 2022-12-31 SPECTRUM PHARMACEUTICALS INC (edgar:831547) Free cash flow: -97262000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:41:29Z Snapshot: 51fa4a59e4dde224557b669386eabfc60a89a8a03d558f01a77928fae4b901d2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/831547?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -96989000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1134497 Filing: 000083154723000007 Input fundies:CapitalExpenditure: 273000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/831547/000083154723000007/sppi-20221231.htm#1142516 Filing: 000083154723000007 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

161 filings · 3,932 latest values · 3,939 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000831547, 831547, SPPI, edgar:831547

Also known as NEOTHERAPEUTICS INC, SPECTRUM PHARMACEUTICALS INC, SPECTRUM PHARMACEUTICALS, INC.

SPECTRUM PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation